See more : Unitika Ltd. (UNIKF) Income Statement Analysis – Financial Results
Complete financial analysis of Shenzhen Glory Medical Co.,Ltd. (002551.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shenzhen Glory Medical Co.,Ltd., a leading company in the Medical – Distribution industry within the Healthcare sector.
- Changchun High-Tech Industries (Group) Inc. (000661.SZ) Income Statement Analysis – Financial Results
- Stonehenge Globale Valueaktier (SHIGVAKL.CO) Income Statement Analysis – Financial Results
- Gram Car Carriers ASA (G39.MU) Income Statement Analysis – Financial Results
- Bajaj Holdings & Investment Limited (BAJAJHLDNG.NS) Income Statement Analysis – Financial Results
- Summit Minerals Limited (SUM.AX) Income Statement Analysis – Financial Results
Shenzhen Glory Medical Co.,Ltd. (002551.SZ)
About Shenzhen Glory Medical Co.,Ltd.
Shenzhen Glory Medical Co., Ltd. provides hospital construction and medical system integrated solutions in China. The company is involved in the planning, design, management, and implementation of hospital construction projects; installation of medical professional engineering; and medical software development activities. It also sells medical protective equipment, which includes non-woven surgical gowns and medical surgical kits; and medical disposal protective clothing, isolation gowns, and mask, as well as medical surgical consumables. In addition, the company offers medical information solutions, comprising digital operating rooms, surgical teaching systems, remote surgical consultation, mobile digital video station, central management platforms, and digital pre-hospital emergency platforms. Further it provides professional housing and system management, medical equipment maintenance, medical guidance, carer/accompaniment, logistics management, cleaning and greening, security guard, food, and parking lot management services. Shenzhen Glory Medical Co., Ltd. was founded in 1998 and is based in Shenzhen, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19B | 1.28B | 1.79B | 2.27B | 1.53B | 1.63B | 2.01B | 1.95B | 1.67B | 1.17B | 730.90M | 421.32M | 348.43M | 270.04M | 208.51M | 138.07M | 116.37M |
| Cost of Revenue | 995.28M | 1.05B | 1.43B | 1.57B | 1.20B | 1.23B | 1.53B | 1.47B | 1.23B | 836.51M | 508.37M | 260.76M | 243.14M | 162.73M | 122.27M | 79.53M | 70.72M |
| Gross Profit | 197.60M | 221.88M | 362.94M | 694.71M | 329.82M | 401.98M | 472.75M | 474.99M | 436.74M | 330.27M | 222.53M | 160.56M | 105.29M | 107.30M | 86.24M | 58.53M | 45.65M |
| Gross Profit Ratio | 16.57% | 17.39% | 20.27% | 30.64% | 21.55% | 24.65% | 23.56% | 24.41% | 26.21% | 28.31% | 30.45% | 38.11% | 30.22% | 39.74% | 41.36% | 42.40% | 39.23% |
| Research & Development | 40.07M | 48.18M | 52.37M | 61.17M | 47.89M | 46.24M | 50.72M | 46.00M | 41.49M | 31.04M | 20.77M | 11.33M | 7.74M | 5.82M | 5.35M | 3.62M | 4.11M |
| General & Administrative | 40.72M | 40.17M | 43.07M | 39.30M | 31.75M | 24.18M | 41.59M | 33.25M | 43.65M | 22.74M | 17.41M | 14.48M | 12.75M | 8.01M | 11.70M | 7.62M | 3.95M |
| Selling & Marketing | 13.34M | 24.68M | 71.91M | 89.64M | 64.61M | 67.13M | 69.92M | 67.81M | 59.26M | 49.96M | 34.87M | 25.61M | 18.80M | 13.67M | 10.91M | 7.74M | 6.08M |
| SG&A | 172.36M | 64.86M | 114.97M | 128.93M | 96.35M | 91.31M | 111.51M | 101.06M | 102.91M | 72.70M | 52.28M | 40.09M | 31.55M | 21.68M | 22.61M | 15.35M | 10.04M |
| Other Expenses | 106.40M | 115.38M | 100.59M | 121.36M | 58.97M | 30.13M | -102.37K | 7.79M | 4.52M | 2.48M | 7.28M | 3.32M | 1.69M | 694.59K | 480.47K | -179.45K | 1.31M |
| Operating Expenses | 318.83M | 228.42M | 267.93M | 311.46M | 203.22M | 197.41M | 228.27M | 245.12M | 238.80M | 176.23M | 127.32M | 89.89M | 68.22M | 49.09M | 39.70M | 26.06M | 20.12M |
| Cost & Expenses | 1.31B | 1.28B | 1.70B | 1.88B | 1.40B | 1.43B | 1.76B | 1.72B | 1.47B | 1.01B | 635.69M | 350.65M | 311.36M | 211.83M | 161.96M | 105.59M | 90.84M |
| Interest Income | 8.73M | 6.94M | 5.18M | 8.70M | 7.74M | 5.45M | 7.31M | 6.98M | 8.84M | 17.52M | 21.70M | 16.96M | 18.43M | 1.54M | 202.12K | 235.91K | 128.91K |
| Interest Expense | 3.59M | 4.44M | 7.22M | 16.98M | 12.08M | 11.45M | 11.96M | 19.02M | 14.16M | 10.19M | 6.37M | 2.86M | 542.44K | 2.33M | 2.17M | 478.68K | 515.02K |
| Depreciation & Amortization | 99.39M | 128.26M | 83.25M | 31.07M | 42.59M | 36.53M | 33.24M | 29.32M | 27.52M | 24.09M | 13.39M | 11.85M | 11.49M | 9.95M | 3.66M | 3.03M | 1.95M |
| EBITDA | -24.59M | -252.57M | 158.19M | 414.20M | 121.07M | 209.60M | 277.02M | 211.13M | 218.03M | 168.55M | 115.66M | 87.31M | 63.86M | 63.64M | 51.62M | 32.08M | 26.08M |
| EBITDA Ratio | -2.06% | 9.86% | 11.36% | 19.33% | 11.80% | 16.67% | 13.93% | 14.00% | 14.73% | 16.99% | 18.92% | 24.28% | 19.73% | 26.22% | 24.76% | 25.78% | 24.92% |
| Operating Income | -121.22M | 791.36K | 126.73M | 370.30M | 141.04M | 122.83M | 225.41M | 154.38M | 167.83M | 131.28M | 88.60M | 69.23M | 50.35M | 57.14M | 46.74M | 28.76M | 23.38M |
| Operating Income Ratio | -10.16% | 0.06% | 7.08% | 16.33% | 9.21% | 7.53% | 11.23% | 7.93% | 10.07% | 11.25% | 12.12% | 16.43% | 14.45% | 21.16% | 22.42% | 20.83% | 20.09% |
| Total Other Income/Expenses | -6.42M | -385.17M | -4.01M | -1.83M | -1.41M | 30.13M | -450.95K | 7.79M | 4.50M | 1.91M | 7.17M | 3.32M | 1.69M | 694.59K | 480.47K | -179.45K | 1.31M |
| Income Before Tax | -127.64M | -384.37M | 89.05M | 368.47M | 70.82M | 152.96M | 225.31M | 162.15M | 172.33M | 133.38M | 95.77M | 72.55M | 52.04M | 57.84M | 47.22M | 28.58M | 24.69M |
| Income Before Tax Ratio | -10.70% | -30.13% | 4.97% | 16.25% | 4.63% | 9.38% | 11.23% | 8.33% | 10.34% | 11.43% | 13.10% | 17.22% | 14.94% | 21.42% | 22.65% | 20.70% | 21.22% |
| Income Tax Expense | 33.18M | -56.47M | 1.03M | -1.48M | -5.60M | 18.25M | 36.13M | 25.83M | 28.88M | 22.38M | 18.29M | 12.90M | 7.73M | 11.06M | 7.71M | 3.96M | 2.57M |
| Net Income | -148.89M | -327.90M | 88.02M | 369.95M | 59.76M | 97.71M | 175.16M | 114.15M | 119.06M | 102.16M | 73.76M | 58.33M | 44.16M | 46.39M | 39.88M | 24.12M | 22.01M |
| Net Income Ratio | -12.48% | -25.70% | 4.92% | 16.32% | 3.90% | 5.99% | 8.73% | 5.87% | 7.14% | 8.76% | 10.09% | 13.84% | 12.67% | 17.18% | 19.13% | 17.47% | 18.92% |
| EPS | -0.18 | -0.39 | 0.10 | 0.46 | 0.08 | 0.15 | 0.26 | 0.17 | 0.18 | 0.16 | 0.11 | 0.09 | 0.07 | 0.09 | 0.08 | 0.05 | 0.06 |
| EPS Diluted | -0.18 | -0.39 | 0.10 | 0.44 | 0.07 | 0.15 | 0.26 | 0.17 | 0.18 | 0.15 | 0.11 | 0.09 | 0.07 | 0.09 | 0.08 | 0.05 | 0.06 |
| Weighted Avg Shares Out | 844.81M | 844.76M | 844.68M | 798.31M | 705.97M | 666.06M | 664.74M | 666.60M | 653.81M | 638.96M | 663.87M | 650.30M | 620.36M | 488.82M | 477.49M | 443.25M | 378.15M |
| Weighted Avg Shares Out (Dil) | 844.81M | 844.76M | 869.60M | 837.05M | 845.25M | 666.06M | 665.50M | 671.49M | 661.92M | 666.74M | 664.21M | 650.39M | 620.36M | 488.82M | 477.49M | 443.25M | 378.15M |
Source: https://incomestatements.info
Category: Stock Reports